Literature DB >> 31149133

A CHILD WITH LARON SYNDROME ASSOCIATED WITH VASCULITIS.

R Unsal Sac1, M A Tasar1, U Tiras2, S Savas Erdeve3, Y Dallar Bilge1.   

Abstract

BACKGROUND AND OBJECTIVES: Levels of insulin-like growth factor-I are characteristically low in Laron syndrome which is a factor that has important roles on vascular health and development. Congenital insulin-like growth factor-I deficiency was reported to be associated with some vascular disorders. However, vasculitis diseases and Laron Syndrome association has not been reported in English literature up to date. PATIENT: We report the case of a two and a half years old Turkish girl, who was diagnosed as Laron syndrome when she was 12 months old. She presented with acute vasculitis lesions. Her physical examination and laboratory studies did not reveal a specific infectious agent or also an autoimmune disease was not detected. Her lesions disappeared during hospitalization without a complication.
CONCLUSION: Since insulin-like growth factor-I reduces endothelial cell oxidative stress and maintains the structural integrity of vessels, some common mechanisms might be responsible for the occurrence of vasculitis in this patient with Laron syndome. The role of insulin-like growth factor-I and recombinant human insulin-like growth factor-I treatment choice in vasculitis diseases is a matter of investigation.

Entities:  

Keywords:  Child; Growth hormone; Insulin-like growth factor; Laron syndrome; vasculitis

Year:  2016        PMID: 31149133      PMCID: PMC6535243          DOI: 10.4183/aeb.2016.465

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   0.877


  19 in total

1.  Severe diabetic retinopathy: a rare complication of acromegaly.

Authors:  H A Tran; N Petrovsky; A J Field
Journal:  Intern Med J       Date:  2002 Jan-Feb       Impact factor: 2.048

Review 2.  The essential role of IGF-I: lessons from the long-term study and treatment of children and adults with Laron syndrome.

Authors:  Z Laron
Journal:  J Clin Endocrinol Metab       Date:  1999-12       Impact factor: 5.958

3.  Cotherapy with recombinant human insulin-like growth factor I and insulin improves glycemic control in type 1 diabetes. RhIGF-I in IDDM Study Group.

Authors:  K M Thrailkill; T Quattrin; L Baker; J E Kuntze; P G Compton; P M Martha
Journal:  Diabetes Care       Date:  1999-04       Impact factor: 19.112

4.  Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging.

Authors:  Lora C Bailey-Downs; Matthew Mitschelen; Danuta Sosnowska; Peter Toth; John T Pinto; Praveen Ballabh; M Noa Valcarcel-Ares; Julie Farley; Akos Koller; Jim C Henthorn; Caroline Bass; William E Sonntag; Zoltan Ungvari; Anna Csiszar
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2011-10-21       Impact factor: 6.053

5.  Postnatal head growth deficit among premature infants parallels retinopathy of prematurity and insulin-like growth factor-1 deficit.

Authors:  Chatarina Löfqvist; Eva Engström; Jon Sigurdsson; Anna-Lena Hård; Aimon Niklasson; Uwe Ewald; Gerd Holmström; Lois E H Smith; Ann Hellström
Journal:  Pediatrics       Date:  2006-06       Impact factor: 7.124

6.  Postnatal serum insulin-like growth factor I deficiency is associated with retinopathy of prematurity and other complications of premature birth.

Authors:  Ann Hellström; Eva Engström; Anna-Lena Hård; Kerstin Albertsson-Wikland; Björn Carlsson; Aimon Niklasson; Chatarina Löfqvist; Elisabeth Svensson; Sture Holm; Uwe Ewald; Gerd Holmström; Lois E H Smith
Journal:  Pediatrics       Date:  2003-11       Impact factor: 7.124

7.  Diabetic retinopathy in two patients with congenital IGF-I deficiency (Laron syndrome).

Authors:  Zvi Laron; Dov Weinberger
Journal:  Eur J Endocrinol       Date:  2004-07       Impact factor: 6.664

8.  IGF-I activity may be a key determinant of stroke risk--a cautionary lesson for vegans.

Authors:  M F McCarty
Journal:  Med Hypotheses       Date:  2003-09       Impact factor: 1.538

Review 9.  Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels.

Authors:  Patrice Delafontaine; Yao-Hua Song; Yangxin Li
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-11-06       Impact factor: 8.311

10.  Endogenous hormones and carotid atherosclerosis in elderly men.

Authors:  A W van den Beld; M L Bots; J A M L L Janssen; H A P Pols; S W J Lamberts; D E Grobbee
Journal:  Am J Epidemiol       Date:  2003-01-01       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.